Franck J. Kamga Gninzeko; Michael S. Valentine; Cindy K. Tho; Sahil R. Chindal; Susan Boc; Sneha Dhapare; Mohammad A. M. Momin; Amr Hassan; Michael Hindle; Dale R. Farkas; P. Worth Longest; Rebecca L. Heise

Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome

The Journal of Maternal-Fetal & Neonatal Medicine 33(16) (2018)

Cristina Ramos Navarro; Manuel Sánchez Luna; Susana Zeballos-Sarrato; Noelia González‐Pacheco

RETREATMENT WITH SURFACTANT IN VERY LOW BIRTH WEIGHT PRETERM INFANTS: RISK PREDICTORS AND THEIR INFLUENCE ON NEONATAL OUTCOMES

Revista Paulista de Pediatria 39 (2020)

Walusa Assad Gonçalves‐Ferri; Adriana Carnevale da Silva; E.M.F. Sacramento; Cristina Calixto; Davi Casale Aragon; Jamil Pedro de Siqueira Caldas

Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis

Archives of Medical Science 19(5) (2020)

Caihong Qiu; Cui Ma; Nana Fan; Xiaoyu Zhang; Guofeng Zheng

A systematic scoping review of the use of surfactant replacement therapy for respiratory distress syndrome in preterm neonates in low- and middle-income countries

Frontiers in Pediatrics 13 (2025)

Caris A. Price; Lloyd Tooke; Heather Joy Zar; Brenda May Morrow

In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome

Frontiers in Pediatrics 5 (2017)

Francesca Ricci; Fabrizio Salomone; Elke Kuypers; Daan R. M. G. Ophelders; Maria Nikiforou; Monique G. M. Willems; Tobias Krieger; Xabier Murgia; Matthias Christian Hütten; Boris W. W. Kramer; Federico Bianco

Bioequivalence requirements for orally inhaled and nasal drug products and use of novel physiologically based biopharmaceutics modeling approaches for assessing in vivo performance

Journal of Pharmaceutical Sciences 114(2) (2024)

Aravind Rachapally; Rajkumar Boddu; Sivacharan Kollipara; Tausif Ahmed

Curosurf Versus BLES in the Treatment of Preterm Neonates with Respiratory Distress Syndrome: A Randomized Clinical Trial

Innovative Journal of Pediatrics 35(3) (2025)

Vahidreza Ostadmohammadi; Mohammad Javad Namazi; Mahsa Rezasoltani; Mohammad Reza Sharif; Farzaneh Sharifi; Ahmad Safari; Alireza Sharif

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome

Health Science Reports 1(4) (2018)

Elizabeth Stockley; Ronald Valotaire; Michael R. Miller; Orlando da Silva

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress

PLoS ONE 17(6) (2022)

Nader Jahanmehr; Reyhane Izadi; Abbas Habibolahi; Setareh Yousefzadeh; Soheila Khodakarim

Evaluation of the Potential Association Between Cannabinoid Receptor 2 Gene Q63R Polymorphism (Rs35761398) and Risk of RDS Development in Preterm Neonates

Iranian Journal of Pediatrics In Press(In Press) (2018)

Sima Binaafar; Majid Kalani; Fatemeh Nayeri; Shiva Irani; Vahid Salimi; Mamak Shariat; Nikoo Niknafs; Hosein Dalili; Elaheh Amini; Tahereh Esmaeilnia Shirvani; Amirkamal Hardani; Roya Taheritafti; Nasrin Ghasemi-Fakhr; Mohsen Ghadami; Javad Tavakkoly‐Bazzaz; Ali Rashidi‐Nezhad

Comparison between two natural surfactant poractant alfa and bovine lipid extract in respiratory distress syndrome amongst preterm neonates-a quasi-experimental study

International Journal of Contemporary Pediatrics 9(1) (2021)

Srikanta Baske; Sudip Kumar Saha; Partha Pratim Pal

Comparison of porcine versus bovine surfactant in preterm respiratory distress syndrome: Evidence from real‐world data. A multicentre collaboration from Karnataka

Pediatric Pulmonology 59(7) (2024)

Abhishek Somasekhara Aradhya; Sharath S. Ghalige; Babu S. Madarkar; Pruthvishree HV; Praveen Venkatagiri; Prashant Urs; Daizy Ngangom; Sandeep Rangaiah; Vimal Kumar; Chinnaraja Harini; Arpna Bansal; Maneesha Panduranga Halkar

Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates

BMC Pediatrics 23(1) (2023)

Fatemeh Sabzevari; Mahdieh Eslamian; Fatemeh Karami Robati; Bahareh Bahmanbijari; Zahra Daei Parizi; Zahra Jamali

Evaluation of beractant, poractant alfa and calfactant use in newborns with respiratory distress syndrome: A single-center retrospective study

The Annals of Clinical and Analytical Medicine 14(12) (2023)

Cengizhan Ceylan; Şeyma Tetik Rama; Ayse Huzeyme Cınar; Murat Konak; Saime Sündüs Uygun; Mehmet Ozturk; Hanifi Soylu

Comparison of the Effectiveness of Beraksurf and Curosurf Exogenous Surfactants in the Treatment of Respiratory Distress Syndrome in Preterm Neonates: A Double-blind Randomized Study in the West of Iran

Current Pediatric Reviews 21(2) (2024)

Fatemeh Eghbalian; Behnaz Basiri; Seyedeh Behnaz Hatami; Narges Mohamadi Parsa; Ensiyeh Jenabi

Expression of Concern for Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial [Iran J Pediatr. 2016;26(5): e5743]

Iranian Journal of Pediatrics 34(5) (2024)

Vahid Ziaee

Comparison of Efficacy of Beractant (SURVANTA®) and Poractant Alfa (CUROSURF®) in Preterm Infants With Respiratory Distress Syndrome in Tawam Hospital, Al Ain, UAE: A Retrospective Study

Cureus 16(11) (2024)

Fahad Butt; Huda Mohamad; Nour Abusallout; Alaa Zaineh; Feryal El khatib; Sarah Abdulrahman; Sara Hamwi; Mohamed Rahmani; Mustafa Alabdullatif